Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Remission and regression of diabetic nephropathy.
Hovind P, Tarnow L, Parving HH. Hovind P, et al. Curr Hypertens Rep. 2004 Oct;6(5):377-82. doi: 10.1007/s11906-004-0057-x. Curr Hypertens Rep. 2004. PMID: 15341691 Review.
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
Hovind P, Tarnow L, Oestergaard PB, Parving HH. Hovind P, et al. Kidney Int Suppl. 2000 Apr;75:S56-61. Kidney Int Suppl. 2000. PMID: 10828763

This difference was ascribed to elevated VEGF levels in nephropathic men: 51.8 [22.0-410] versus 22.0 [22.0-308] ng/L, P < 0. 001. ...Plasma VEGF was below the detection limit (22.0 ng/L) in 60 patients with nephropathy and 93 patients with normoalbuminuria, P &l

This difference was ascribed to elevated VEGF levels in nephropathic men: 51.8 [22.0-410] versus 22.0 [22.0-308] ng/L, P < 0. 001.

Progression of diabetic nephropathy.
Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Hovind P, et al. Kidney Int. 2001 Feb;59(2):702-9. doi: 10.1046/j.1523-1755.2001.059002702.x. Kidney Int. 2001. PMID: 11168952

The average decline in GFR was 4.0 +/- 0.2 mL/min/year and even lower (1.9 +/- 0.5 mL/min/year) in the 30 persistently normotensive patients, none of whom had ever received antihypertensive treatment (P < 0.01). A multiple linear regression analysis revealed a significa

The average decline in GFR was 4.0 +/- 0.2 mL/min/year and even lower (1.9 +/- 0.5 mL/min/year) in the 30 persistently normotensive patients …
Evolving strategies for renoprotection: diabetic nephropathy.
Parving HH, Hovind P, Rossing K, Andersen S. Parving HH, et al. Curr Opin Nephrol Hypertens. 2001 Jul;10(4):515-22. doi: 10.1097/00041552-200107000-00006. Curr Opin Nephrol Hypertens. 2001. PMID: 11458033 Review.
Remission of nephrotic-range albuminuria in type 1 diabetic patients.
Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH. Hovind P, et al. Diabetes Care. 2001 Nov;24(11):1972-7. doi: 10.2337/diacare.24.11.1972. Diabetes Care. 2001. PMID: 11679467

More women (37%) than men (16%) obtained remission (P = 0.01). In the remission group compared with the no-remission group, mean arterial blood pressure (mean +/- SEM) was reduced (102 +/- 1 vs. 106 +/- 1 mmHg, P < 0.01), the rate of decline in GFR was diminished

More women (37%) than men (16%) obtained remission (P = 0.01). In the remission group compared with the no-remission group, mean arte …
Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1.
Hovind P, Tarnow L, Rossing P, Teerlink T, Stehouwer CD, Emeis JJ, Parving HH. Hovind P, et al. Am J Kidney Dis. 2001 Dec;38(6):1376-80. doi: 10.1053/ajkd.2001.29261. Am J Kidney Dis. 2001. PMID: 11728978 Clinical Trial.
A linear regression analysis revealed a borderline significant relationship between rate of decline in GFR and tHcy (P = 0.069) and PAI-1 (P = 0.087). Analysis of the rate of decline in GFR and tertiles of tHcy and PAI-1 revealed that increasing levels of tHcy were …
A linear regression analysis revealed a borderline significant relationship between rate of decline in GFR and tHcy (P = 0.069) and P …
Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy.
Hansen HP, Hovind P, Jensen BR, Parving HH. Hansen HP, et al. Kidney Int. 2002 Jan;61(1):163-8. doi: 10.1046/j.1523-1755.2002.00092.x. Kidney Int. 2002. PMID: 11786097

During recumbency a non-significant rise was recorded from night- to daytime in albuminuria (22%, -8 to 61, P=0.15), simultaneously with an increase in GFR of 9.0% (3.4 to 14.5, P < 0.005) and mean arterial blood pressure (MABP) of 8.0% (4.3 to 11.7, P &lt

During recumbency a non-significant rise was recorded from night- to daytime in albuminuria (22%, -8 to 61, P=0.15), simultaneously w …
Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.
Parving HH, Hovind P. Parving HH, et al. Curr Hypertens Rep. 2002 Oct;4(5):387-93. doi: 10.1007/s11906-002-0069-3. Curr Hypertens Rep. 2002. PMID: 12217258 Review.
Birth weight--a risk factor for progression in diabetic nephropathy?
Jacobsen P, Rossing P, Tarnow L, Hovind P, Parving HH. Jacobsen P, et al. J Intern Med. 2003 Mar;253(3):343-50. doi: 10.1046/j.1365-2796.2003.01109.x. J Intern Med. 2003. PMID: 12603502
62 results
Jump to page
Feedback